Individual phases of contextual fear conditioning differentially modulate dorsal and ventral hippocampal GluA1-3, GluN1-containing receptor complexes and subunits.
In contextual fear conditioning (CFC), the use of pharmacological and lesion approaches has helped to understand that there are differential roles for the dorsal hippocampus (DH) and the ventral hippocampus (VH) in the acquisition, consolidation and retrieval phases. Concomitant analysis of the DH and the VH in individual phases with respect to α-amino-3-hydroxy-5-methyl-4-isoxazole propionate receptors and N-methyl-D-aspartate receptor subtype N1 (GluN1)-containing complexes (RCC) and subunits has not been reported so far. Herein, CFC was performed in mice that were euthanized at different time points. DH and VH samples were taken for the determination of RCC and subunit levels using BN- and SDS-PAGE, respectively, with subsequent Western blotting. Evaluation of spine densities, morphology, and immunohistochemistry of GluA1 and GluA2 was performed. In the acquisition phase levels of GluA1-RCC and subunits in VH were increased. In the consolidation phase GluA1- and GluA2-RCC levels were increased in DH and VH, while both receptor subunit levels were increased in the VH only. In the retrieval phase GluA1-RCC, subunits thereof and GluA2-RCC were increased in DH and VH, whereas GluA2 subunits were increased in the VH only. GluN1-RCC levels were increased in acquisition and consolidation phase, while subunit levels in the acquisition phase were increased only in the DH. The immunohistochemical studies in the individual phases in subareas of hippocampus supported immunochemical changes of GluA1 and GluA2 RCC's. Dendritic spine densities and the prevalence of thin spines in the acquisition phase of VH and mushroom spines in the retrieval phase of the VH and DH were increased. The findings from the current study suggest different receptor and receptor complex patterns in the individual phases in CFC and in DH and VH. The results propose that different RCCs are formed in the individual phases and that VH and DH may be involved in CFC.
Department of Pediatrics, Medical University of Vienna, Austria.
Sunetra
S
Sase
Department of Pediatrics, Medical University of Vienna, Austria.
Ajinkya
A
Sase
Department of Pediatrics, Medical University of Vienna, Austria.|CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria.
Fernando J
FJ
Sialana
CF Imaging, Medical University of Vienna, Austria.
Marion
M
Gröger
CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria.
Keiryn L
KL
Bennett
Institute of Biology, Otto Von Guericke University, Magdeburg, Germany.
Oliver
O
Stork
Department of Pediatrics, Medical University of Vienna, Austria.
Gert
G
Lubec
Department of Pediatrics, Medical University of Vienna, Austria.
Lin
L
Li
D000818:Animals; D026481:Blotting, Far-Western; D002853:Chromatography, Liquid; D003213:Conditioning, Psychological / Q000502:physiology*; D049229:Dendritic Spines / Q000378:metabolism; D004591:Electrophoresis, Polyacrylamide Gel; D004597:Electroshock; D005239:Fear / Q000502:physiology*; D006624:Hippocampus / Q000166:cytology / Q000378:metabolism*; D007150:Immunohistochemistry; D047468:Immunoprecipitation; D008297:Male; D013058:Mass Spectrometry; D008568:Memory / Q000502:physiology; D008810:Mice, Inbred C57BL; D009483:Neuropsychological Tests; D018091:Receptors, AMPA / Q000378:metabolism*; D016194:Receptors, N-Methyl-D-Aspartate / Q000378:metabolism*; D013037:Spatial Behavior / Q000502:physiology*
D018091:Receptors, AMPA; D016194:Receptors, N-Methyl-D-Aspartate
AMPA receptor; NMDA receptor; contextual fear conditioning; dendritic spines; receptor complex